Propac To Recommend Reclassification Of Five Leukemia/Lymphoma Diagnosis Related Groups
In Brief: AACR To Have Fur Symposia, Including One With ASCO; McConnell Names TRTP Director
LAK/IL-2 Therapy Could Halt Kidney Cancer Deaths: DeVita
Cancer Education Applications Suspended Pending Restructuring
Caution Advised for Hormone Replacement Therapy
NLMs Grateful MED Aids Data Searches
FDA Committee Approves NDA for Mitxantrone
Trending Stories
- Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing - ACOG says it will no longer accept federal funding
- Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- Lou Weiner: Poetry and art help us imagine my mother’s world as a hidden child of the Holocaust
- When public service ends abruptly, do books provide solace? An escape? Perspective?
Former NIH and FDA employees tell us what they are reading in 2025